Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers

SIMPLE SUMMARY: Early detection of ovarian cancer is a significant clinical challenge, with most women presenting with advanced stages of disease at initial diagnosis. The aim of this study was to evaluate the role of MAGEC3 and BRCA2 in epithelial ovarian cancer progression. We evaluated the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Omole, Emmanuel B., Aijaz, Iqbal, Ellegate, James, Isenhart, Emily, Desouki, Mohamed M., Mastri, Michalis, Humphrey, Kristen, Dougherty, Emily M., Rosario, Spencer R., Nastiuk, Kent L., Ohm, Joyce E., Eng, Kevin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562635/
https://www.ncbi.nlm.nih.gov/pubmed/36230652
http://dx.doi.org/10.3390/cancers14194724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562635/
https://www.ncbi.nlm.nih.gov/pubmed/36230652
http://dx.doi.org/10.3390/cancers14194724

Ejemplares similares